---
$id: https://graph.org.ai/products/commodity/51182023
$type: Product
source: UNSPSC
code: "51182023"
title: "Mebolazine"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mebolazine

**UNSPSC Code**: 51182023
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C42H68N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69C642I19V, chemically known as 17beta-hydroxy-2alpha,17-dimethyl-5alpha-androstan-3-one azine but generally known as mebolazine, which bears US NIH Compound Identifier 9571069. European Medicines Agency schedules Mebolazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08666MIG. The term MEBOLAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). MEBOLAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mebolazine under HS 29372900 and SITC 54153. As of Q4 2014, MEBOLAZINE remains the US FDA Preferred Term for this commodity. Mebolazine bears US NLM identifiers UMLS ID C0604275 and NCI Concept Code C90641. SMILES: OC1(C2(C(C3C(C4(C(CC3)C/C(=N/N=C3/CC5C(C6C(C7C(C(O)(CC7)C)(CC6)C)CC5)(CC3C)C)C(C4)C)C)CC2)CC1)C)C.

